Treatment-ready
Keep regimen authorization and coverage aligned before the chair is booked.
Connect treatment workflows, specialty billing rules, and reimbursement on one platform built for cancer care. Learn why Unlimited Systems is the trusted choice for Oncology practice management and RCM software.
Community oncology carries financial risk that general practice management software was never designed for. A single treatment day can combine a high-cost biologic, an administration sequence billed by the minute, a payer-specific step-therapy requirement, and discarded drug that has to be documented to be paid for.
When those details live in separate systems, the gaps show up as denied J-codes, unbilled wastage, expired authorizations, and drug margin no one can explain until the month closes. Oncology-specific rules and connected data are what keep those exceptions from becoming write-offs.
★★★★★5/5Product screenshot
Oncology workspace preview coming soon
Trusted Payer & EHR Integration Partners
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
Our connected workflows are built to make you and your work easier to do and increase your revenue.
Keep regimen authorization and coverage aligned before the chair is booked.
Validate J-codes, dose details, and JW/JZ modifiers before submission.
Give teams one view of denials, drug margin, and A/R priorities.
Highest buy-and-bill complexity in any specialty.
Where revenue is at risk
HCPCS J-codes for high-cost agents; ASP+6% margin compression under Medicare; biosimilar substitution rules.
How the platform addresses this
| Drug | Code | Route | Channel | Cost | PA | Billing notes |
|---|---|---|---|---|---|---|
| Keytruda (pembrolizumab) | J9271 | IV | Part B | $180K/yr | Yes | Single-dose vial; JW required. |
| Opdivo (nivolumab) | J9299 | IV | Part B | $150K/yr | Yes | Weight-based dosing complexity. |
| Herceptin (trastuzumab) | J9355 | IV/SQ | Part B | $70K/yr | Yes | Biosimilar pressure from Kanjinti and Ogivri. |
| Avastin (bevacizumab) | J9035 | IV | Part B | $55K/yr | Yes | Multi-use; partial vial tracking is critical. |
| Zometa (zoledronic acid) | J3489 | IV | Part B | $2K/yr | Sometimes | Generic available; AWP vigilance needed. |
Cabinet integration: Cabinet-to-EHR integration is critical because oncology practices may stock 30-60+ J-code drugs. Without ADC integration, partial-vial charge capture and wastage documentation gaps become a primary source of revenue leakage.
Move schedules, patient data, and charge details without duplicate entry.
Therapy documentation and financial workflow exchange.
Less manual work, clearer margin, and faster follow-up.
“JW/JZ and J-code edits recovered revenue we used to write off each month.”
- Director of Revenue Cycle
Eight connected capabilities, grouped around the way your practice works.
Keep registration and treatment calendars in sync.
Verify coverage and catch charge risk early.
Post payments, route denials, and prioritize A/R.
See margin, performance, and value-based results.
The work that generic platforms leave to your staff is the work oncology margin actually turns on.
Compare the capabilities that matter most in buy-and-bill care.
| Capability | Unlimited Financials | General platforms |
|---|---|---|
| JW/JZ waste automation | Built in | Often manual |
| Oncology dose validation | Preconfigured | Custom setup |
| Bi-directional EHR exchange | Supported | Varies |
| Oncology billing guidance | Included | General support |
Need to compare a specific workflow?
Adjust three inputs to see an illustrative annual impact range.
Adjust the inputs to match your practice.
Enter your work email to unlock your estimated annual financial impact.
A focused workflow review can show what to keep, what to fix, and whether a change is worth planning.
Start with a workflow review. We map J-codes, JW/JZ rules, authorizations, interfaces, and payer requirements before a transition is proposed.
Specialty rules and connected data keep your team focused on the exceptions that need judgment.
Coverage and authorization stay tied to the regimen.
Dose, vial, and modifier checks happen before filing.
Denials and A/R are ranked by value and filing risk.

Preview the MAC jurisdiction and oncology checks mapped into the workflow.
Medicare contractor
Most bi-directional integrations take 6–12 weeks, including workflow mapping, testing, and cutover support.
Each module is configured for the codes, modifiers, and payer rules oncology teams work with — not adapted from generic billing software.
Oncology and specialty practices, on what changed after moving to Unlimited Financials.

I'd love to set up a call to talk about SCOA, and the success we've had with Unlimited Financials.
The system continues to grow with features as it should, with how healthcare changes. So, if you are looking for a company that is innovative and truly cares, I would recommend Unlimited Financials.
Unlimited Financials has been the easiest and best practice management system I have used. It is easy to navigate and do what I need to do.
I would recommend Unlimited Financials to other specialty practices.
We transitioned to Unlimited Financials in 2024... the team and platform are absolutely amazing.
We have been on Unlimited Financials for over three years and love it. Our claims are being processed faster and more efficiently, which means we are receiving payment more quickly.
I'd love to set up a call to talk about SCOA, and the success we've had with Unlimited Financials.
The system continues to grow with features as it should, with how healthcare changes. So, if you are looking for a company that is innovative and truly cares, I would recommend Unlimited Financials.
Unlimited Financials has been the easiest and best practice management system I have used. It is easy to navigate and do what I need to do.
I would recommend Unlimited Financials to other specialty practices.
We transitioned to Unlimited Financials in 2024... the team and platform are absolutely amazing.
We have been on Unlimited Financials for over three years and love it. Our claims are being processed faster and more efficiently, which means we are receiving payment more quickly.
Connect with an oncology RCM expert for a personal workflow walkthrough, and see where your current setup is creating avoidable revenue risk.
★★★★★5/5.png)